Urinary Mycotoxin Testing
Abstract
Urinary mycotoxin testing is unvalidated for evaluation of environmental exposure via inhalation, diagnosis of chronic inflammatory response syndrome (CIRS) or the resolution of any parameter of illness. Urinary mycotoxin test results do not indicate antifungal use in oral, sublingual and intranasal forms. Rampant antifungal use has contributed to fungal and bacterial resistance and multi-nuclear atrophy via beta-tubulin upregulation in vulnerable populations. The Centers for Disease Control (CDC) does not condone urinary mycotoxin testing in conjunction with antifungal use. By contrast, in 2008, the US Government Accountability Office (GAO) supported a strict case definition for exposure to water-damaged buildings. Globally, 60–100% of healthy individuals have mycotoxins in their urine. Urinary mycotoxin presence does not correlate with human health parameters. Urinary mycotoxin testing most strongly indicates ingestion of stored food. There are few cases of human illness associated with mycotoxicosis. Good farming practices reduce these risks further.
Symptom Clusters
Related Papers
- Medizinisch klinische Diagnostik bei Schimmelpilzexposition in Innenräumen – Update 2023 (AWMF-Register-Nr. 161/001)Pneumologie · 2024 · 6 shared tags
- Sick building syndrome (SBS) and exposure to water-damaged buildings: Time series study, clinical trial and mechanismsNeurotoxicology and Teratology · 2006 · 6 shared tags
- 30+ years of knowledge creation: Indoor Air 1991–2021Indoor Air · 2022 · 5 shared tags
- Kaksi toksisuustestiä syötävien ja myrkyllisten sienten sekä sisätilapölyjen analytiikassaAaltodoc (Aalto University) · 2021 · 5 shared tags
- Synergistic interaction in simultaneous exposure to Streptomyces californicus and Stachybotrys chartarumEnvironmental Health Perspectives · 2004 · 5 shared tags
- Spores of Aspergillus versicolor isolated from indoor air of a moisture-damaged building provoke acute inflammation in mouse lungsInhalation Toxicology · 2002 · 5 shared tags